Abiopharma

BIOADAPTIVES, INC. (BDPT)

Symbol	BDPT
Name	BIOADAPTIVES, INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	89128 United States NV 2620 Regatta Drive Suite 102
Telephone	(702) 659-8829
Fax	—
Email	—
Website	http://www.bioadaptives.com
Incorporation	US
Incorporated On	2013
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC;NASDAQ
Auditor	Pubco Reporting Services Inc;Boladale Lawal & Co (Chartered Accountants);
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001575142
Description	BioAdaptives Inc. is a cutting-edge research and development company focused on pioneering nutraceutical solutions for significant health challenges in humans and animals. Unlike competitors producing generic products, BioAdaptives leverages advanced scientific research to create innovative, proprietary formulations using safe, natural extracts from plants, algae, fungi, and cyanobacteria. Our flagship products include nutraceuticals that enhance the body’s natural stem cell production for cellular repair and regeneration, nootropics that deliver immediate cognitive enhancement with sustained long-term benefits, and natural weight-loss solutions that stimulate peptide secretion for safe and effective results. With a commitment to innovation and quality, BioAdaptives is positioned to capture growing demand in the global nutraceutical market, delivering transformative health solutions backed by science. Additional info from OTC: BioAdaptives Inc. is a cutting-edge research and development company focused on pioneering nutraceutical solutions for significant health challenges in humans and animals. Unlike competitors producing generic products, BioAdaptives leverages advanced scientific research to create innovative, proprietary formulations using safe, natural extracts from plants, algae, fungi, and cyanobacteria. Our flagship products include nutraceuticals that enhance the body’s natural stem cell production for cellular repair and regeneration, nootropics that deliver immediate cognitive enhancement with sustained long-term benefits, and natural weight-loss solutions that stimulate peptide secretion for safe and effective results. With a commitment to innovation and quality, BioAdaptives is positioned to capture growing demand in the global nutraceutical market, delivering transformative health solutions backed by science.

2026-07-23 11:30

BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches

2026-07-16 12:30

BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness

2026-07-15 12:30

BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells

2026-06-25 18:48

BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity

2026-05-20 20:15

BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery

2026-03-03 21:05

FRISSORA MARK P 🟢 acquired 257.8K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Mar 01, 2026 | Filing ID: 000388

2026-02-03 21:06

FRISSORA MARK P 🟢 acquired 256.5K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Feb 01, 2026 | Filing ID: 000209

2026-01-05 21:45

FRISSORA MARK P 🟢 acquired 228.6K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Jan 01, 2026 | Filing ID: 000020

2025-12-04 00:04

Director FRISSORA MARK P 🟢 acquired 202.5K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Dec 01, 2025 | Filing ID: 001712

2025-11-04 21:30

Director FRISSORA MARK P 🟢 acquired 138.2K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Nov 01, 2025 | Filing ID: 001528